CELLTRION PHARM, INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 99,200 KRW | +3.77% |
|
+3.23% | +7.59% |
| Jan. 16 | Celltrion Holdings Actively Pursuing Nasdaq Listing | MT |
| Jan. 02 | Celltrion's Shares Climb After Merger With Affiliate | DJ |
ETFs positioned on Celltrion Pharm, Inc.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.75% | 2 M€ | -14.14% | ||
| 0.03% | 0 M€ | +14.35% | ||
| 0.01% | 0 M€ | +8.13% | - | |
| 0.01% | 0 M€ | +7.38% | - | |
| 0.01% | 0 M€ | +5.56% | - | |
| 0.01% | 4 M€ | -4.41% | - | |
| 0.00% | 0 M€ | +4.28% | - | |
| 0.00% | 0 M€ | +3.30% | - | |
| 0.00% | 0 M€ | +7.77% | - | |
| 0.00% | 0 M€ | +5.66% | - | |
| 0.00% | 0 M€ | +4.96% | - | |
| 0.00% | 0 M€ | +3.53% | - |
Celltrion Pharm Inc is a Korea-based company engaged in the manufacture and sale of pharmaceuticals. The Companyâs products include hepatotonics, analgesics, antipyretics, anti-inflammatory drugs, antihistamines, respiratory apparatus drugs, circularly system drugs, digestives and stomachic drugs, hormone disease drugs, antibiotics, nutrients, tonics, and other drugs. It also provides ethical drugs and over-the-counter (OTC) drugs. The Company distributes its products in domestic market and overseas markets such as Philippines, Kazakhstan, Cambodia and other Southeast Asia countries.
Sector
Pharmaceuticals
Calendar
2024-05-09
- Q1 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| +7.59% | 3.03B | |
| +20.68% | 43.57B | |
| +20.70% | 22.7B | |
| +16.63% | 14.32B | |
| +11.26% | 13.42B | |
| +45.97% | 11.83B | |
| -8.84% | 6.98B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +12.33% | 5.51B |
- Stock Market
- Equities
- A068760 Stock
- Funds and ETFs Celltrion Pharm, Inc.